The iron chelator deferoxamine decreases myeloma cell survival

OBJECTIVE: This study evaluated serum ferritin (SF) levels and investigated their relationships with various clinical markers in patients with multiple myeloma (MM). Furthermore, the effects and molecular mechanism of deferoxamine (DFO) in myeloma cells were studied. METHODS: Clinical data from 84 p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Int Med Res
Hlavní autoři: Yang, Feifei, Wu, Zhaoxian, Dai, Dan, Zhang, Lei, Zhang, Xiuqun, Zhang, Xuezhong, Xu, Yanli
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2021
Témata:
Retrospective Clinical Research Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7841871/
https://ncbi.nlm.nih.gov/pubmed/33478296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060520987396
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky